bioRxivPharmacology & ToxicologyPreprint
Low exposure to lithium does not induce nephrogenic diabetes insipidus but microcystic dilations of collecting ducts in a long-term rat model
N. Tabibzadeh, M. Klein, M. Try, J. Poupon, P. Houillier, C. Klein, L. Cheval, G. Crambert, S. Lasaad, L. Chevillard, B. Megarbane
Abstract
Lithium induces nephrogenic diabetes insipidus (NDI) and microcystic chronic kidney disease (CKD). As clinical studies suggested that NDI is dose-dependent and CKD time-dependent, we investigated the effects of low exposure to lithium in a long-term rat model. Sprague-Dawley rats were randomly fed during six months with normal diet (controls), addition of lithium to diet, or addition of lithium and amiloride to diet, allowing reaching low steady-state plasma lithium concentrations (0.25{+/-}0.06 and 0.43{+/-}0.16 mmol/L, respectively). Exposure to low plasma lithium concentrations did not induce NDI but microcystic dilations of kidney tubules, identified as collecting ducts (CDs) using immunofluorescent staining. Both hypertrophy, characterized by an increase in the ratio of nuclei per tubular area, and microcystic dilations were observed. Principal cell-to-intercalated cell ratio was higher in dilated than in hypertrophied tubules. There was no correlation between aquaporin-2 mRNA levels and cellular remodelling of CDs. Amiloride/lithium co-administration did not allow significant consistent morphometric and cellular composition changes compared to lithium administration. To conclude, rat low exposure to lithium did not induce overt NDI but microcystic dilations of CDs, which include a marked alteration in cell composition of hypertrophied and dilated CDs, suggesting two distinct underlying pathophysiological mechanisms.
- organism: rat
- assay: imaging
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RNA-Seq and Protein Mass Spectrometry in Microdissected Kidney Tubules Reveal Signaling Processes that Initiate Lithium-Induced Diabetes Insipidus
Chih‐Chien Sung, Lihe Chen, … Mark A. Knepper·Kidney InternationalPeer-reviewed·Mar 4, 2019
- A corticopapillary Gdf15 response links maladaptive collecting duct remodeling to polyuria during lithium exposure
Lucie Zerarga, Marie Himbert, … Nahid Tabibzadeh·bioRxiv·Oct 19, 2026
- Effects of NAD⁺ Repletion with Nicotinamide Riboside on Obesity-Induced Chronic Kidney Disease and Renal Cell Lipotoxicity
Morgane Decarnoncle, Louise Pierre, … Florian Juszczak·Scientific ReportsPeer-reviewed·Apr 9, 2026
- Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD mice
Piplu Bhuiyan, Wenjia Zhang, … Huafeng Wei·Journal of Neuroimmune PharmacologyPeer-reviewed·Mar 17, 2025
- Renal arterial dysfunction, impaired pressure natriuresis and salt-sensitivity in a mouse model of Cushing syndrome
Hannah M. Costello, Céline Grenier, … Matthew A. Bailey·bioRxiv·Dec 11, 2024
- NAD+ activates renal metabolism and protects from chronic kidney disease in a model of Alport syndrome
Bryce A. Jones, Debora L. Gisch, … Moshe Levi·JCI InsightPeer-reviewed·Mar 9, 2025